ftInvstr
COHANCE · Healthcare ₹456.0 -0.66% Mkt Cap ₹17538 Cr

COHANCE

Healthcare Drug Manufacturers - Specialty & Generic
₹456.0
-0.66% today · 30d +4.59%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for COHANCE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹422 Cr
-23.13% YoY
NET PROFIT
₹-45 Cr
-197.39% YoY
OPM
3.09%
-19.31pp YoY
EPS
₹-0.63
PE 164.07
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-38.7%, h3=-36.6% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
COHANCE164.078.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
44
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 5
Growth STEADY 56
Profitability AVERAGE 45
Technicals NEUTRAL 62
Risk LOW 90
Key Stats
TTM PE
164.07
P/B
4.41
52W HIGH
₹1038.9
OFF HIGH
-56.11%
MKT CAP
₹17538 Cr
◉ Active Signals
MACDNeutral-0.0819
RSI(14)Neutral53.11
Street Consensus
9 analysts
₹508.33
mean target
Low ₹315.0Now ₹456.0High ₹1150.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold COHANCE and at what entry.

Sign up freeSign in